Safety, effectiveness, and acceptability of antenatal penicillin allergy evaluation: a systematic review
American Journal of Obstetrics and Gynecology · 2026-01 · 234 (1) · 35-60
DOI: 10.1016/j.ajog.2025.08.033 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift American Journal of Obstetrics and Gynecology, 2026-01. Verfasst von Lindsay Reddeman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Canada. Electronic address: lindsay.reddeman@mail.utoronto.ca. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Hypersensitivity, Penicillins, Prenatal Care. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Approximately 8% to 13% of pregnant patients report a penicillin allergy. Penicillins and other beta-lactams are widely used in pregnancy but are often avoided in these patients, resulting in suboptimal therapy, antimicrobial resistance, higher costs, and increased morbidity for patients and neonates. True penicillin allergy is rare, and 95% of unverified penicillin allergies are delabeled upon evaluation. Although penicillin allergy evaluation is safe and recommended for pregnant patients, few patients are assessed. Research concerning antenatal penicillin allergy evaluation is accelerating, and we undertook a systematic review to summarize this growing body of evidence for obstetrical providers. A comprehensive search of Medline, Embase, CINAHL, the Cochrane Central Register of Controlled Trials, PubMed (ahead-of-print and non-Medline records), and ClinicalTrials.gov was conducted in collaboration with a medical information specialist. There were no restrictions on study language, date, or design. All peer-reviewed studies of pregnant people reporting an unverified penicillin allergy and undergoing penicillin allergy evaluation with ≥5 participants were included. Case reports, non-peer-reviewed sources, and studies regarding desensitization of verified penicillin-allergic patients were excluded. Title/abstract review, full-text review, and data extraction were completed independently by 2 authors. Conflicts were resolved by a third author. Studies were evaluated using validated quality assessment tools. Nineteen studies (N=2085) were eligible for inclusion. In total, 1956 (93.81%) participants were delabeled through various approaches: direct oral challenge (18.61%), penicillin skin test and oral challenge (51.12%), penicillin skin test and intravenous challenge (2.97%), penicillin skin test alone (18.00%), history review (1.94%), and unspecified methods (7.41%). Acceptance of penicillin allergy evaluation was 60.88%. Overall, 17 mild and 8 mild delayed allergy-related adverse reactions occurred, requiring minimal intervention. There were 3 severe allergy-related adverse reactions: 2 participants experienced anaphylaxis (managed with intramuscular epinephrine and observation), and 1 patient had mild drug-induced hepatitis (resolved with observation). No hospital transfers were required. No adverse antenatal events were recorded. Penicillin allergy evaluation in pregnancy is safe, effective, and acceptable to patients. The case is strong for expanding access to optimize antimicrobial therapy, reduce antibiotic resistance, and improve outcomes for pregnant people and neonates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Canada. Electronic address: lindsay.reddeman@mail.utoronto.ca.
- Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Canada.
- Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Canada; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Canada; Division of Matern…
- Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, Canada.
- Sidney Liswood Health Science Library, Mount Sinai Hospital, Toronto, Canada.
Zitieren
APA
Reddeman, L., Lim, J. W. J., Murphy, K. E., Fahmy, D., Walsh, C., & Harris, K. (2026). Safety, effectiveness, and acceptability of antenatal penicillin allergy evaluation: a systematic review. American Journal of Obstetrics and Gynecology, 234(1), 35-60. https://doi.org/10.1016/j.ajog.2025.08.033
Vancouver
Reddeman L, Lim JWJ, Murphy KE, Fahmy D, Walsh C, Harris K. Safety, effectiveness, and acceptability of antenatal penicillin allergy evaluation: a systematic review. American Journal of Obstetrics and Gynecology. 2026;234(1):35-60. doi:10.1016/j.ajog.2025.08.033
BibTeX
@article{Reddeman2026,
author = {Reddeman, Lindsay and Lim, Justin W J and Murphy, Kellie E and Fahmy, David and Walsh, Chris and Harris, Kristin},
title = {Safety, effectiveness, and acceptability of antenatal penicillin allergy evaluation: a systematic review},
journal = {American Journal of Obstetrics and Gynecology},
year = {2026},
volume = {234},
number = {1},
pages = {35--60},
doi = {10.1016/j.ajog.2025.08.033}
}
EUVIMED